At the 16th Conference on Retroviruses and Opportunistic Infections (CROI) in Montreal, David Evans talks with Tony Mills, MD, a private practice physician and researcher at the University of California in Los Angeles, about the latest in antiretroviral research. Dr. Mills gives his take on the surprising results of an Isentress (raltegravir) clinical trial, the latest news from Gilead about their four-in-one pill, and the promise of viral eradication.

7 1/2 minutes. Click here for the transcript.